Tobias Rautio

Publikationer

2023

Steven R. Baginski, Tobias Rautio, Lorna A. Nisbet, Karin Lindbom, Xiongyu Wu, Johan Dahlén, Craig Mckenzie, Henrik Green (2023) The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC-QTOF-MS and synthesized reference standards Journal of Analytical Toxicology, Vol. 47, s. 826-834 Vidare till DOI

Tobias Rautio, Daan Vangerven, Johan Dahlén, Shimpei Watanabe, Robert Kronstrand, Svante Vikingsson, Peter Konradsson, Xiongyu Wu, Henrik Gréen (2023) In vitro metabolite identification of acetylbenzylfentanyl, benzoylbenzylfentanyl, 3-fluoro-methoxyacetylfentanyl, and 3-phenylpropanoylfentanyl using LC-QTOF-HRMS together with synthesized references Drug Testing and Analysis, Vol. 15, s. 711-729 Vidare till DOI

2022

Tobias Rautio, Jonathan Thornell, Henrik Gréen, Peter Konradsson, Johan Dahlén, Xiongyu Wu (2022) An improved procedure for the synthesis of fourteen 4-OH and 3-MeO-4OH metabolites of fentanyl analogues from two intermediates on multi-gram scale Synthetic Communications, Vol. 52, s. 392-401 Vidare till DOI

2020

Jakob Wallgren, Svante Vikingsson, Tobias Rautio, Enas Nasr, Anna Åstrand, Shimpei Watanabe, Robert Kronstrand, Henrik Gréen, Johan Dahlén, Xiongyu Wu, Peter Konradsson (2020) Structure elucidation of urinary metabolites of fentanyl and five fentanyl analogues using LC-QTOF-MS, hepatocyte incubations and synthesized reference standards Journal of Analytical Toxicology, Vol. 44 Vidare till DOI

2019

Svante Vikingsson, Tobias Rautio, Jakob Wallgren, Anna Åstrand, Shimpei Watanabe, Johan Dahlén, Ariane Wohlfarth, Peter Konradsson, Xiongyu Wu, Robert Kronstrand, Henrik Green (2019) LC-QTOF-MS Identification of Major Urinary Cyclopropylfentanyl Metabolites Using Synthesized Standards Journal of Analytical Toxicology, Vol. 43, s. 607-614 Vidare till DOI